1. What Is the Digital Pathology Market?
The Digital Pathology Market covers the scanning systems and computational analysis platforms that digitise glass histology slides into high-resolution whole-slide images for viewing, archiving, sharing, and AI-assisted analysis, supplied to pathology laboratories and research institutions. Pathologists and researchers use digital pathology to improve workflow efficiency, enable remote consultation, and apply computational analysis to tissue sections that glass-based review does not permit at scale. The market serves clinical anatomic pathology, oncology biomarker scoring, clinical research, and pharmaceutical drug development, with adoption accelerating following FDA clearance of digital pathology as a primary diagnosis tool. It includes whole-slide image scanners, the storage and viewing platform, and the AI-based image analysis applications, with demand driven by pathologist shortage, remote consultation, and AI-powered biomarker quantification.
2. Digital Pathology Market Size & Forecast
3. Emerging Technologies
- Whole-slide image scanners digitising glass slides at diagnostic resolution for primary diagnosis and remote review.
- AI biomarker scoring quantifying PD-L1, Ki-67, and other markers with reduced pathologist variability.
- Remote pathology consultation connecting specialist pathologists to sites without local expertise.
- Computational clinical trial biomarker analysis replacing manual scoring for pharmaceutical development.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Point Of Care Diagnostics Market.
4. Key Market Opportunity
The largest near-term opportunity in the Digital Pathology market lies in hospital laboratories adopting whole-slide imaging for primary diagnosis workflow and intra-laboratory slide sharing. A second, faster-growing opportunity lies in oncology centres using AI-assisted biomarker scoring for standardised companion diagnostic measurement. As adoption broadens, the addressable opportunity is expanding from early deployments toward wider commercial use, with North America positioned for the most rapid growth through 2034.
5. Top Companies in the Digital Pathology Market
The following organisations hold leading positions in the Digital Pathology Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Leica Biosystems (Danaher)
- Philips Digital Pathology
- Hamamatsu Photonics
- 3DHistech
- Akoya Biosciences
- PathAI
- Paige AI
- ibex Medical Analytics
- Visiopharm
- Sectra
6. Market Segmentation
The Digital Pathology Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Component | Whole-Slide ScannerPlatform SoftwareAI Analysis Application |
| By Application | OncologyNon-Oncology Anatomic PathologyResearch and Drug Development |
| By End User | Hospital LabReference LabPharmaceutical |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Digital Pathology Market trajectory over the forecast period:
FDA Clearance for Primary Diagnosis Using Digital Pathology in 2017 and Subsequent Expanded Clearances.FDA clearance for primary diagnosis using digital pathology in 2017 and subsequent expanded clearances removed the regulatory barrier that had limited adoption of whole-slide imaging to secondary review in the United States. Pathologists can now make primary diagnoses from scanned slides rather than requiring review of physical glass slides. This regulatory change opened the largest clinical market for digital pathology systems. Leica Biosystems, Philips, Hamamatsu, and 3DHistech supply the leading scanner platforms. Adoption is accelerating as health systems recognise the workflow and consultation benefits.
AI-Based Tissue Analysis Applications Are the Highest-Growth Segment.AI-based tissue analysis applications are the highest-growth segment, as trained models quantify biomarker expression, score immune infiltrate, detect mitoses, and segment tumour regions with accuracy approaching pathologist agreement for specific tasks. AI scoring reduces the variability and subjectivity of manual biomarker assessment. Pharmaceutical companies are adopting computational pathology for clinical trial biomarker analysis and drug development. This AI application layer is becoming a distinct software market above the scanner hardware.
Pathologist Shortage Is a Structural Tailwind.Pathologist shortage is a structural tailwind, as the global pathologist workforce is insufficient to handle growing biopsy and cytology volumes, particularly in markets where cancer diagnoses are increasing. Digital pathology enables remote consultation that connects scarce specialist pathologists to underserved settings. This workforce constraint supports adoption even where the direct workflow benefit is marginal.
For related market intelligence, see the In Vitro Diagnostics Market.
8. Segmental Analysis
By component, the whole-slide scanner segment dominated the Digital Pathology Market in 2025, as scanner hardware represents the required infrastructure for digitising slides in every digital pathology programme.
By application, the oncology segment is projected to register the highest CAGR in the Digital Pathology Market through 2034, as AI biomarker scoring and companion diagnostic standardisation drive oncology digital pathology adoption, driving the fastest-growing application category within the market.
9. Regional Analysis
Regional demand patterns across the Digital Pathology Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
Europe dominated the Digital Pathology Market in 2025, accounting for the largest share of clinical installations. Moreover, the Netherlands and Sweden were early adopters of digital pathology in public health systems, and Germany, France, and the UK have expanded adoption. In addition, European pathology laboratory networks have advanced digital slide sharing and teleconsultation. Philips is headquartered in Europe and concentrated early sales domestically This early regulatory acceptance and network adoption anchors European leadership.
Highest CAGR Region
North America is projected to register the highest CAGR in the Digital Pathology Market through 2034. The primary driver is accelerating US adoption following FDA clearance for primary diagnosis, which removed the primary barrier to widespread clinical use. Moreover, AI pathology applications developed predominantly by US companies including PathAI, Paige, and ibex are gaining FDA clearance and driving computational pathology adoption. The combination of these demand drivers and an expanding base positions North America for sustained growth outperformance through 2034.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Digital Pathology Market was valued at USD 4.25 Bn in 2025 and is projected to reach USD 26.19 Bn by 2034, growing at a CAGR of 22.4% over the 2026–2034 forecast period.
The Digital Pathology Market is projected to grow at a CAGR of 22.4% from 2026 to 2034.
Europe dominated the Digital Pathology Market in 2025, accounting for the largest share of clinical installations.
The leading companies in the Digital Pathology Market include Leica Biosystems (Danaher), Philips Digital Pathology, Hamamatsu Photonics, 3DHistech, Akoya Biosciences, PathAI, Paige AI, ibex Medical Analytics, Visiopharm, Sectra.
Fda clearance for primary diagnosis using digital pathology in 2017 and subsequent expanded clearances.
By component, the whole-slide scanner segment dominated the Digital Pathology Market in 2025, as scanner hardware represents the required infrastructure for digitising slides in every digital pathology programme.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.